| Previous Close | 4.1200 |
| Open | 4.1600 |
| Bid | 0.0000 x 800 |
| Ask | 0.0000 x 3000 |
| Day's Range | 4.1200 - 4.2490 |
| 52 Week Range | 0.6620 - 4.6800 |
| Volume | 3,482,369 |
| Avg. Volume | 5,821,219 |
| Market Cap | 726.073M |
| Beta (5Y Monthly) | 0.82 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.8650 |
| Earnings Date | Aug. 09, 2021 - Aug. 13, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.00 |
- Zacks
Is the Options Market Predicting a Spike in Sesen Bio (SESN) Stock?
Investors need to pay close attention to Sesen Bio (SESN) stock based on the movements in the options market lately.
- Business Wire
Sesen Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Jun 18, 2021--Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today reported the grant of a non-statutory stock option to one new employee in connection with the employee’s commencement of employment with Sesen Bio. The addition of this new team member represents a continuation of the buildout of the Sesen Bio team in support of its transformation into a commercial-stage company a
- Simply Wall St.
Sesen Bio (NASDAQ:SESN) Is In A Strong Position To Grow Its Business
There's no doubt that money can be made by owning shares of unprofitable businesses. By way of example, Sesen Bio...
© 2021 Verizon Media. All rights reserved.
